Home

In the high profile and fast-changing generics market, generics and biosimilar companies and manufacturers need to make timely, data-driven decisions. Our industry experts and data scientists help make sense of the vast amount of market performance, API, patent, and regulatory data so you can continue to broaden patient access to medicines and keep the engines of innovation going.

With access to insights on supply chain, market share, patents and exclusivities, and more, our solutions help you identify new portfolio opportunities, plan a stable supply chain, maintain regulatory compliance and stay ahead of the competition.